Application of macrophages in obesity treatment and blood sugar regulation
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 鲲石生物科技(深圳)有限公司
- Publication Date
- 2021-08-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine and relates to the new medical application of engineered macrophages, in particular to the application of macrophages expressing IL-4 protein in treating obesity and regulating blood sugar. Background technique
[0002] With the rapid development of the economy and the acceleration of urbanization, people's lifestyle and dietary structure have undergone tremendous changes, and the overweight and obese population is increasing year by year. Studies at home and abroad have shown that obesity is an important factor in inducing hypertension, cardiovascular and cerebrovascular diseases, type 2 diabetes, hyperlipidemia, fatty liver and other diseases. A type of obesity in which fat deposition in the body begins to develop centered on the heart and abdomen is called central obesity or central obesity, which is a type of obesity that is more harmful than systemic obesity. The World Health Organization has list...